Showing results 1 to 1 of 1
| Issue Date | Title | Journal Title |
|---|---|---|
| 2026 | Pan-Asian subgroup analysis of EV-302/KEYNOTE-A39: a phase 3 study to evaluate enfortumab vedotin and pembrolizumab in patients with untreated advanced urothelial carcinoma | INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY |